complex
interplay
cytokin
chemokin
regul
innat
adapt
immun
respons
pathogen
specif
cytokin
chemokin
express
drive
activ
immun
effector
cell
recruit
tissu
infect
site
herein
inocul
dog
leishmania
braziliensi
antigen
plu
saponin
lbsap
vaccin
well
vaccin
compon
use
realtim
pcr
evalu
kinet
dermal
express
mrna
cytokin
chemokin
h
inocul
also
evalu
correl
cytokin
chemokin
express
dermal
cellular
lbsap
vaccin
induc
high
level
express
h
respect
furthermor
observ
posit
correl
express
express
express
suggest
mix
cytokin
microenviron
develop
immun
vaccin
inocul
saponin
adjuv
alon
induc
chemokin
cytokin
express
profil
similar
observ
lbsap
group
chemokin
express
regul
lbsap
vaccin
express
initi
highest
lbsap
group
h
express
highest
lb
group
inform
kinet
immun
respons
vaccin
gain
use
dog
model
help
elucid
mechan
factor
involv
protect
respons
leishmania
infect
aid
establish
ration
approach
develop
vaccin
canin
viscer
leishmaniasi
human
viscer
leishmaniasi
heterogen
diseas
caus
oblig
intracellular
protozoan
parasit
genu
leishmania
transmit
bite
femal
phlebotomin
sand
fli
desjeux
dog
infect
canin
viscer
leishmaniasi
cvl
constitut
main
domest
reservoir
play
central
role
transmiss
cycl
parasit
human
dean
therefor
canin
vaccin
may
practic
effect
method
reduc
incid
human
viscer
leishmaniasi
may
also
provid
basi
develop
similar
vaccin
human
gradoni
hommel
et
al
mauel
search
potenti
vaccin
cvl
variou
approach
involv
dog
model
employ
use
purifi
fraction
parasit
extract
eg
fucos
mannos
ligand
antigen
borjacabrera
et
al
da
silva
et
al
parasit
cultur
excretedsecret
antigen
lemesr
et
al
lemesr
et
al
shown
particular
promis
addit
remark
result
obtain
follow
vaccin
dog
kill
parasit
vaccin
giunchetti
et
al
lasri
et
al
mayrink
et
al
moreira
et
al
panaro
et
al
vitorianosouza
et
al
roatt
et
al
vaccin
repres
excel
tool
immunoprophylaxi
control
cvl
consid
wide
spectrum
antigen
well
cost
safeti
giunchetti
et
al
lasri
et
al
mayrink
et
al
moreira
et
al
panaro
et
al
vitorianosouza
et
al
moreov
anim
receiv
saponin
adjuv
major
advers
reaction
minor
local
swell
indic
dog
overal
toler
candid
vaccin
appear
adequ
giunchetti
et
al
moreira
et
al
vitorianosouza
et
al
understand
cellular
immun
respons
dog
infect
leishmania
parasit
crucial
vaccin
design
straussayali
et
al
involv
immun
respons
leishmaniainfect
dog
yet
establish
organ
express
mrna
elev
antigenstimul
peripher
blood
mononuclear
cell
cours
experiment
infect
bone
marrow
natur
infect
dog
quinnel
et
al
santosgom
et
al
lage
et
al
suggest
sever
cvl
also
mark
balanc
splenic
product
type
cytokin
predomin
accumul
consequ
increas
parasit
load
progress
symptom
furthermor
menezessouza
et
al
show
dog
high
skin
parasit
exhibit
predominantli
immunoregulatori
pattern
immun
respons
character
increas
express
mrna
express
bone
marrow
symptomat
dog
quinnel
et
al
high
express
recent
detect
local
skin
lesion
l
infantum
infect
dog
brachelent
et
al
thu
contradictori
find
proven
role
cvl
progress
still
unclear
need
studi
clarifi
real
function
natur
histori
canin
diseas
menezessouza
et
al
express
antigenstimul
peripher
blood
mononuclear
cell
skin
lesion
bone
marrow
infect
dog
shown
elev
quinnel
et
al
brachelent
et
al
chamizo
et
al
straussayali
et
al
thu
increas
respons
main
mechan
involv
protect
immun
respons
dog
infect
l
l
infantum
activ
macrophag
kill
intracellular
amastigot
vouldouki
et
al
potenti
role
chemokin
leishmania
infect
includ
host
defens
function
leucocyt
recruit
particip
cellmedi
immun
cell
activ
antileishmania
activ
rot
von
andrian
chemokin
play
vital
role
regul
immun
variou
diseas
affect
skin
includ
human
cutan
leishmaniasi
gupta
et
al
howev
immunomodulatori
process
trigger
chemokin
assess
immunogen
vaccin
cvl
well
studi
therefor
address
issu
present
studi
success
immun
infect
leishmania
spp
requir
particip
innat
adapt
immun
respons
cytokin
chemokin
microenviron
promot
immedi
recruit
cell
drive
immun
respons
prospect
studi
investig
kinet
express
cytokin
chemokin
mrna
skin
dog
immun
leishmania
braziliensi
antigen
plu
saponin
adjuv
lbsap
vaccin
well
inocul
separ
compon
vaccin
detail
propos
studi
present
approv
ethic
committe
use
experiment
anim
universidad
feder
de
ouro
preto
ouro
preto
mg
brazil
subject
use
mongrel
dog
male
femal
month
old
born
rais
kennel
center
anim
scienc
universidad
feder
de
ouro
preto
dog
treat
anthelmint
vaccin
rabi
tecpar
curitiba
pr
brazil
canin
distemp
type
adenoviru
coronaviru
parainfluenza
parvoviru
leptospira
vanguard
htlp
pfizer
anim
health
new
york
ny
usa
two
day
prior
experi
dorsal
area
anim
shave
local
reaction
observ
dog
subdivid
four
group
three
dog
per
group
sap
group
inocul
mg
saponin
sigma
chemic
co
st
loui
mo
usa
lb
group
inocul
g
l
braziliensi
total
protein
lbsap
group
inocul
g
l
braziliensi
total
protein
mg
saponin
group
control
inocul
equival
volum
steril
salin
solut
adjuv
antigen
dilut
steril
salin
solut
total
volum
l
follow
applic
gener
anaesthet
thiopentax
itapira
sp
brazil
mgkg
bodi
weight
inocul
intraderm
inject
shave
dorsal
area
anim
interv
skin
biopsi
collect
inocul
area
store
c
requir
rna
analysi
descript
kinect
studi
biopsi
tissu
perform
h
histolog
analysi
perform
accord
vitorianosouza
et
al
briefli
histolog
examin
morphometr
analysi
leucocyt
differenti
count
section
stain
haematoxylin
eosin
kinet
cell
migrat
evalu
within
three
skin
layer
outer
dermi
inner
dermi
hypodermi
predomin
cell
inflammatori
infiltr
distribut
within
skin
layer
assess
quantit
morphometr
analysi
inflammatori
cell
present
skin
layer
perform
acquir
digit
imag
premark
area
imag
captur
magnif
use
leica
microcamera
leica
microsystemsswitzerland
ltd
heerbrugg
switzerland
leica
applic
suit
softwar
version
analyz
aid
leica
qwin
softwar
order
identifi
type
cell
recruit
site
differ
inocul
site
inflammatori
cell
neutrophil
eosinophil
macrophag
lymphocyt
count
result
express
percentag
herein
correl
analysi
cellular
cytokin
chemokin
mrna
express
skin
anim
perform
total
rna
extract
homogen
approxim
mg
skin
tissu
ml
trizol
reagent
invitrogen
brasil
paulo
sp
brazil
rotor
stator
lysat
incub
room
temperatur
min
mix
chloroform
l
tube
invers
centrifug
g
min
c
aqueou
phase
collect
rna
extract
mean
sv
total
rna
isol
system
promega
madison
wi
usa
accord
recommend
manufactur
elut
concentr
purifi
total
rna
determin
tabl
sequenc
forward
f
revers
r
primer
use
realtim
pcr
quantif
mrna
express
skin
biopsi
immun
dog
primer
sequenc
measur
od
ratio
nm
use
nanovu
ge
healthcar
usa
confirm
integr
extract
rna
electrophoresi
fraction
rna
sampl
perform
denatur
agaros
gel
verifi
ribosom
rna
rrna
band
procedur
includ
dnase
treatment
step
effici
step
evalu
pcr
amplif
cdna
reaction
mixtur
without
addit
thermoscript
enzym
quantit
pcr
run
perform
two
intern
control
assess
potenti
contamin
genom
dna
revers
transcriptas
ad
reagent
puriti
cdna
ad
firststrand
cdna
synthes
g
total
rna
use
thermoscript
rtpcr
system
invitrogen
brasil
paulo
sp
brasil
oligodt
primer
accord
manufactur
instruct
primer
design
aid
gene
runner
ver
hast
softwar
inc
use
specif
canin
sequenc
obtain
genbank
http
wwwgenbanknlmnihgov
sequenc
primer
employ
list
tabl
primer
synthes
eurogentec
southampton
uk
reconstitut
nucleasefre
water
realtim
pcr
perform
abi
prism
dna
sequenc
detect
system
use
l
sybr
green
pcr
master
mix
pe
appli
biosystem
foster
citi
ca
usa
l
mm
primer
l
cdna
dilut
carri
final
volum
l
sampl
incub
c
min
submit
cycl
c
c
min
time
fluoresc
data
collect
effici
pair
primer
evalu
serial
dilut
cdna
accord
protocol
develop
pe
appli
biosystem
evalu
gene
express
perform
three
replic
analys
amount
target
rna
normal
respect
endogen
control
refer
gene
gene
gapdh
data
gener
mean
ct
method
use
mean
valu
ct
control
group
calibr
livak
schmittgen
pcr
product
clone
pgemt
easi
vector
promega
sequenc
check
specif
use
abi
autom
sequenc
pe
appli
biosystem
dye
termin
kit
statist
analys
perform
aid
graphpad
prism
softwar
packag
ver
graphpad
softwar
san
diego
ca
usa
normal
data
establish
use
kolmogorovsmirnov
test
oneway
analysi
varianc
tukey
post
test
use
investig
differ
group
associ
cytokin
express
leukocyt
chemokin
express
leukocyt
dermi
dog
investig
use
pearson
rank
correl
case
differ
consid
signific
p
valu
evalu
cytokin
mrna
express
essenti
improv
understand
protect
cellular
immun
respons
induc
vaccin
canin
leishmaniasi
therefor
evalu
express
mrna
dermi
dog
h
inocul
lbsap
vaccin
compon
fig
h
express
lbsap
group
higher
sap
group
interestingli
express
also
higher
lbsap
group
sap
group
signific
differ
express
observ
fig
carri
detail
analysi
correl
type
type
immunoregulatori
cytokin
fig
found
lb
group
posit
correl
p
r
sap
group
posit
correl
p
r
p
r
p
r
lbsap
group
posit
correl
observ
p
r
p
r
lb
group
posit
correl
observ
p
r
lbsap
group
posit
correl
observ
p
r
evalu
express
mrna
chemokin
h
inocul
lbsap
vaccin
individu
compon
fig
h
inocul
express
mrna
lbsap
group
time
lb
group
saponin
sap
group
l
braziliensi
antigen
plu
saponin
lbsap
group
signific
differ
p
compar
lb
sap
lbsap
indic
letter
b
c
respect
inocul
express
significantli
upregul
lbsap
group
comparison
express
lb
sap
group
respect
p
h
inocul
express
lb
group
higher
sap
group
respect
p
also
h
inocul
observ
increas
express
chemokin
lb
group
rel
express
sap
lbsap
group
respect
p
addit
express
significantli
higher
lbsap
group
lb
sap
group
h
respect
p
h
inocul
respect
p
signific
differ
express
group
analyz
correl
cytokin
chemokin
express
cellular
outer
inner
dermi
fig
observ
import
correl
chemokin
cytokin
express
cellular
outer
dermi
sap
group
macrophag
express
posit
correl
p
r
neutrophil
express
neg
correl
p
r
lbsap
group
neutrophil
posit
correl
p
r
p
r
p
r
express
inner
dermi
observ
posit
correl
neutrophil
p
r
lb
group
outer
dermi
neg
correl
neutrophil
p
r
sap
group
lbsap
group
observ
posit
correl
neutrophil
p
r
p
r
p
r
well
neg
correl
lymphocyt
p
r
search
new
immunoprophylact
cvl
focu
prospect
antigen
capabl
interven
immun
system
way
induc
specif
immunolog
event
relat
parasit
elimin
develop
immun
infecti
agent
leishmania
spp
requir
concert
action
compon
innat
adapt
immun
system
teixeira
et
al
differenti
regul
type
type
respons
associ
th
cytokin
immun
function
import
studi
adapt
immun
respons
leishmania
infect
menezessouza
et
al
previous
publish
studi
demonstr
lbsap
vaccin
saponin
adjuv
alon
induc
intens
cell
migrat
skin
inocul
dog
thu
trigger
initi
immunogen
event
vitorianosouza
et
al
intens
express
induc
synthas
select
recruit
neutrophil
skin
anim
immun
sap
lbsap
similar
reaction
observ
anim
exhibit
resist
leishmania
infect
vitorianosouza
et
al
base
result
possibl
hypothes
neutrophil
function
front
line
immun
system
respond
immedi
upon
request
direct
migrat
cell
inocul
area
hour
afterward
macrophag
lymphocyt
appear
therefor
neutrophil
particip
effect
adapt
immun
respons
begin
process
vitorianosouza
et
al
sens
investig
kinet
cell
migrat
inocul
area
extrem
relev
sinc
number
type
cell
recruit
immedi
inocul
stimul
innat
immun
system
influenc
develop
acquir
immun
expand
investig
immun
respons
trigger
compon
lbsap
vaccin
evalu
express
cytokin
chemokin
mrna
skin
dog
seek
biomark
immunogen
context
innat
immun
respons
carri
kinet
studi
rel
express
mrna
type
ii
immunoregulatori
cytokin
chemokin
induc
vaccin
separ
compon
site
inocul
h
addit
evalu
correl
cytokin
chemokin
mrna
express
cellular
outer
inner
dermi
analyz
express
mrna
dermi
dog
immun
lbsap
vaccin
found
express
mrna
h
respect
higher
lbsap
group
sap
group
moreov
observ
posit
correl
express
mrna
type
type
ii
cytokin
especi
group
inocul
separ
vaccin
compon
lbsap
vaccin
result
suggest
administr
inocula
microenviron
mix
type
ii
cytokin
develop
skin
anim
cytokin
play
decis
role
regul
immun
respons
direct
l
infantum
determin
prevent
progress
infect
carrillo
moreno
sever
studi
demonstr
mix
cytokin
pattern
associ
resist
suscept
vaccin
leishmaniainfect
model
raziuddin
abdalla
peruhypemagalha
et
al
murin
leishmaniasi
sever
research
observ
synthesi
promot
initi
product
influenc
assembl
matur
tissu
granuloma
howev
experi
address
mechan
regul
express
antileishmani
type
respons
murray
et
al
menezessouza
et
al
menezessouza
et
al
demonstr
asymptomat
leishmaniainfect
anim
present
high
express
concomit
product
author
suggest
inflammatori
cytokin
profil
particularli
driven
could
use
biomark
asymptomat
clinic
form
cvl
studi
hiv
infect
demonstr
effect
macrophag
infect
meylan
et
al
kornbluth
et
al
enhanc
ag
present
function
de
waal
malefyt
et
al
marshal
et
al
associ
improv
diseas
statu
increas
decreas
hiv
viral
load
suggest
contribut
cytokin
maintain
immun
function
follow
infect
robert
et
al
studi
observ
increas
express
chemokin
skin
dog
inocul
variou
vaccin
compon
import
note
chemokin
produc
site
infect
critic
determin
cell
infiltr
site
thu
defin
eventu
outcom
diseas
addit
leishmania
parasit
also
possess
chemotact
factor
select
attract
neutrophil
serv
host
cell
earli
stage
infect
van
zandbergen
et
al
data
show
increas
express
mrna
lbsap
group
h
inocul
addit
signific
upregul
mrna
express
observ
h
inocul
lbsap
group
biopsi
time
level
mrna
higher
lb
group
group
data
demonstr
abil
lbsap
vaccin
induc
product
chemokin
import
recruit
immun
cell
inocul
site
chemokin
preferenti
recruit
monocyt
skin
suggest
host
strategi
control
parasit
ongo
cvl
infect
menezessouza
et
al
addit
express
may
relat
resist
infect
leishmania
follow
cascad
event
lead
parasit
control
l
major
infect
santiago
et
al
studi
observ
higher
level
express
skin
dog
vaccin
lbsap
vaccin
dog
group
first
hour
leishmania
infect
product
amplifi
recruit
neutrophil
infect
site
van
zandbergen
et
al
badolato
et
al
venuprasad
et
al
neutrophil
repres
first
group
leukocyt
arriv
site
infect
thought
serv
trojan
hors
eventu
entri
macrophag
ultim
cellular
host
leishmania
howev
initi
influx
neutrophil
seem
benefici
leishmania
surviv
infect
tissu
van
zandbergen
et
al
interact
cytokin
chemokin
variou
cell
skin
layer
immun
import
understand
mechan
adapt
immun
leishmania
infect
activ
correl
analysi
cell
type
chemokin
express
outer
dermi
show
posit
correl
macrophag
neg
correl
neutrophil
sap
group
data
confirm
role
recruit
macrophag
monocyt
lbsap
group
neutrophil
posit
correl
increas
express
mrna
mix
profil
cytokin
observ
skin
inner
dermi
neutrophil
express
posit
correl
lb
group
case
outer
dermi
express
neutrophil
neg
correl
sap
group
lbsap
group
neutrophil
posit
correl
express
mrna
develop
immun
depend
migrat
appropri
cell
popul
infect
site
turn
depend
express
cytokin
chemokin
addit
knowledg
cell
profil
local
inflammatori
infiltr
provid
supplementari
inform
concern
immun
respons
microenviron
inocul
stewart
et
al
taken
togeth
current
result
allow
us
conclud
skin
microenviron
dog
immun
lbsap
vaccin
mix
cytokin
profil
distinct
express
profil
mrna
data
expect
contribut
establish
ration
strategi
develop
vaccin
immunolog
therapi
viscer
leishmaniasi
grate
use
facil
cebio
universidad
feder
de
mina
gerai
rede
mineira
de
bioterismo
fapemig
support
provis
experiment
anim
